Blackrock Neurotech
Focus: Blackrock Neurotech is a specialized biotechnology company focused on brain-computer interfaces (BCIs) for neurological applications, operating as a pre-revenue/early-stage biotech venture founded in 2008.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Open Jobs
6
Should You Work at Blackrock Neurotech?
AI assessmentBest suited for early-career researchers seeking deep expertise in BCI technology who can tolerate high technical risk and limited near-term career advancement.
Why Work Here
- Pioneering frontier technology in brain-computer interfaces with potential for transformative neurological treatments
- Small, focused team (6 active roles) allows for high-impact individual contribution and rapid skill development
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
INTENT Neural Interface System
Tetraplegia/TetraparesisOpen Jobs (6)
Help build intelligence for Blackrock Neurotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.